** Shares of Australia's Nanosonics NAN.AX rise 13.3% to A$4.95; their highest since August 14, 2023
** NAN says the U.S. Food and Drug Administration has granted De Novo clearance for its latest innovation, the CORIS system
** CORIS is an advanced cleaning system engineered to address one of the most critical challenges in medical device reprocessing: the effective cleaning of flexible endoscopes
** Stock up 61.5% YTD
(Reporting by Rishav Chatterjee in Bengaluru)
((Rishav.Chatterjee@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。